Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV.

Kang, Minhee; Price, Jennifer C; Peters, Marion G; Lewin, Sharon R; Sulkowski, Mark

Kang, Minhee; Price, Jennifer C; Peters, Marion G; Lewin, Sharon R; Sulkowski, Mark.

Afiliación

Kang M; Center for Biostatistics in AIDS Research in the Department of Biostatistics, Harvard T.H. Chan School of Public Health, United States.
Price JC; Division of Gastroenterology, University of California San Francisco School of Medicine, United States.
Peters MG; Department of Medicine, Feinberg School of Medicine, Northwestern University, United States.
Lewin SR; Department of Infectious Diseases, The University of Melbourne, Australia.
Sulkowski M; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Australia.

J Virus Erad ; 9(3): 100344, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37744732

Palabras clave

Clinical trial design; Cure; HBV; HIV; Placebo; TLR agonist

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: J Virus Erad Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google